Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence

Circulation

Volumn 111, Issue 15, 2005, Pages 1985-1991

  Sinaiko, Alan R ^a,f   Steinberger, Julia ^a   Moran, Antoinette ^a   Prineas, Ronald J ^b   Vessby, Bengt ^c   Basu, Samar ^c   Tracy, Russell ^d   Jacobs Jr , David R ^e,f  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY OF VERMONT   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f UNIVERSITY OF OSLO   (Norway)

Author keywords

Insulin; Obesity; Pediatrics; Risk factors

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLAMP; CLUSTER ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CLUSTER ANALYSIS; CONTINENTAL POPULATION GROUPS; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALE; OBESITY; OXIDATIVE STRESS; RISK FACTORS;

EID: 17644381994     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000161837.23846.57     Document Type: Article

References (48)

1. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
2. Dietz WH. Overweight and precursors of type 2 diabetes mellitus in children and adolescents. J Pediatr. 2001;138:453-454.
3. Troiano RP, Flegal KM, Kuczmarski RJ, Campbell SM, Johnson CL. Overweight prevalence in trends for children and adolescents: the National Health and Nutrition Examination Surveys, 1963-1991. Arch Pediatr Adolesc Med. 1995;149:1085-1091.
4. Cook S, Weitman M, Auinger P, Nyguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents. Arch Pediatr Adolesc Med. 2003;157:821-827.
5. Weiss R, Dziura J, Burgurt TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362-2374.
6. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-194.
7. Reaven G. The metabolic syndrome or the insulin resistance syndrome? different names, different concepts, and different goals. Endocrinol Metab Clin North Am. 2004;33:283-303.
8. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care. 1992;15:318-368.
9. Hu FB, Manson JE, Stampfer MJ, Colditz G, Lui S, Solomin CG, Willett WC. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345:790-797.
10. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106:473-481.
11. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev. 1994;74:761-811.
12. Ferrannini E, Natali A, Bell P, Cavallo-Perai P, Lalic N, Miagrone G, on behalf of the European Group for the Study of Insulin Resistance (EGIR). Insulin resistance and hypersecretion in obesity. J Clin Invest 1997;100: 1166-1173.
13. Hollenbeck C, Reaven GM. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab. 1987;64:1169-1173.
14. DeFronzo RA. Lilly Lecture 1987: the triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes. 1988;37:667-687.
15. Jiang X, Srinivasan SR, Webber LS, Wattigney WA, Berenson GS. Association of fasting insulin level with serum lipid and lipoprotein levels in children, adolescents, and young adults: the Bogalusa Heart Study. Arch Intern Med. 1995;155:190-196.
16. Sinaiko AR, Gomez-Marin O, Prineas RJ. Relation of fasting insulin to blood pressure and lipids in adolescents and parents. Hypertension. 1997;30:1554-1559.
17. Rocchini AP, Katch V, Schork A, Kelch RP. Insulin and blood pressure during weight loss in obese adolescents. Hypertension. 1987;10:267-273.
18. Sinaiko AR, Jacobs DR Jr, Steinberger J, Moran A, Luepker R, Rocchini AP, Prineas RJ. Insulin resistance syndrome in childhood: associations of the euglycemic insulin clamp and fasting insulin with fatness and other risk factors in 357 clamp studies. J Pediatr. 2001;139:700-707.
19. Goran MI, Gall GDC Cruz M. Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab. 2003;88:1417-4427.
20. Bacha F, Saad R, Gungor N, Janosky J, Arslanian SA. Obesity, regional fat distribution and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab. 2003;88:2534-2540.
21. Uwaifo GI, Nguyen TT, Keil MF, Russell DL, Nicholson JC, Bonat SH, McDuffie JR, Yanovski JA. Differences in insulin secretions and sensitivity of Caucasian and African American prepubertal children. J Pediatr. 2002;140:673-680.
22. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med. 2002;346:802-810.
23. Slaughter MH, Lohman TG, Baileau RA, Horswill CA, Stillman RJ, Van Loan MD, Bemben DA. Skinfold equations for estimation of body fatness in children and youth. Hum Biol. 1988;60:709-723.
24. Macy E, Hayes T, Tracy R. Variability in the measurement of C-reactive protein in healthy subjects: implication for reference interval and epidemiological applications. Clin Chem. 1997;43:52-58.
25. Basu S. Radioimmunoassay of 8-iso-prostaglandin Fzα: an index for oxidative injury via free radical catalysed lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids. 1998;55:319-325.
26. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition survey. JAMA. 2002;287:356-359.
27. Moran A, Jacobs DR, Steinberger J, Hong C-P, Prineas R, Luepker R, Sinaiko AR. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes. 1999;48:2039-2044.
28. Gower BA, Nagy TR, Goran MI. Visceral fat, insulin sensitivity, and lipids in prepubertal children. Diabetes. 1999;48:1515-1521.
29. Arslanian SA. Metabolic differences between Caucasian and African-American children and the relationship to type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2002;15(S1):509-517.
30. Arslanian SA, Saad R, Lewy V, Danadian K, Janosky J. Hyperinsulinemia in African-American children: decreased insulin clearance, increased insulin secretion and its relationship to insulin sensitivity. Diabetes. 2002;51:3014-3019.
31. Jiang X, Srinivasan SP, Radhakrishnamurthy B, Dalferes ER, Berenson GS. Racial (black-white) differences in insulin secretion and clearance in adolescents: the Bogalusa heart study. Pediatrics. 1999;97:357-360.
32. Goran MI, Bergman RN, Cruz MI, Watanabe RM. Insulin resistance and associated compensatory responses in African-American and Hispanic children. Diabetes Care. 2002;25:2184-2190.
33. Montague CT, O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes. 2000;49:883-888.
34. Frühbeck G, Gómez-Ambrosi J, Muruzábal FJ, Burrell MA. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endorinol Metab. 2001;280:E827-E847.
35. Marette A. Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings. Curr Opin Clin Nutr Metab Care. 2002;5:377-383.
36. Arita Y, Kihara S, Ouchi N, Masahiko T, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophy Res Commun. 1999;257:79-83.
37. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signaling pathways mediations of insulin resistance and β-cell dysfunction? Diabetes. 2003;52:1-8.
38. Rudich A, Tirosh A, Potahnik R, Hemi R, Kanety H, Bashau N. Prolonged oxidative stress impairs insulin-induced GLUT4 trans location in 3T3-LI adipocytes. Diabetes. 1998;47:1562-1569.
39. Nishikawa T, Edelstein D, Brownlee M. The missing link: a single unifying mechanism for diabetic complications. Kidney Int Suppl. 2000;77:526-530.
40. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Taubert K, Tracy RP, Vinicor F. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499-511.
41. Festa A, D'Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation. 2000;102:42-47.
42. McLaughlin T, Abbasi F, Lamendola C, Liang L, Reaven G, Schaaf P, Reaven P. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation. 2002;106:2908-2912.
43. Cook DG, Mendall MA, Whincup PH, Carey IM, Ballam L, Morris JE, Miller GJ, Strachan DP. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis. 2000;149:139-150.
44. Ford ES. C-reactive protein concentration and cardiovascular disease risk factors in children: findings from the National Health and Nutrition Examination Survey 1999-2000. Circulation. 2003;108:1053-1058.
45. Berenson GS, Sathanur RS, Weihang B, Newman WP, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med. 1998;338:1650-1656.
46. Sinaiko AR, Donahue RP, Jacobs DR, Prineas RJ. Relation of rate of growth during childhood and adolescence to fasting insulin, lipids, and systolic blood pressure in young adults. Circulation. 1999;99:1471-1476.
47. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescents: a follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med. 1992;327:1350-1355.
48. Le Roith D, Zick Y. Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care. 2001;24:588-597.